Biogen Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€131.80
Target price
31.10.26
€181.48
Performance (%)
15.17%
Price
30.01.26
€151.80
Summary
This prediction is currently active. The prediction currently has a performance of 15.17%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 4.545% | 4.545% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $217.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat